Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
DECEMBER 2023LIFE SCIENCES REVIEW6As the healthcare landscape undergoes a profound shift toward value-based care, a spotlight shines on the pivotal role of genomics in shaping the future of precision medicine. In an era where the focus extends beyond mere treatment to comprehensive and personalized healthcare solutions, genomics emerges as a linchpin in the quest for more effective and targeted patient care. The global genomics market is soaring, reaching an estimated value of USD 32.65 billion by 2030 at a CAGR of 16.5 percent from 2024 to 2030. The principal factors driving this market growth include increasing government funding, the rising incidence and prevalence of viral diseases and genetic disorders, growing incidents of cancer, and increasing applications of NGS in cancer research. This edition of Life Sciences Review APAC dives into the pivotal contributions within the genomics landscape, offering insights from thought leaders who are sculpting the future of healthcare. Delving deeper into the realm of gene therapy, Rachel Legmann, Senior Director of Technology at Repligen Corp., sheds light on the challenges and innovations in therapeutic viral vector manufacturing. The edition also features Peter Hesse, the vice president and head of genomics business at QIAGEN, who discusses advancements in next-generation sequencing (NGS), focusing on their efforts to enhance targeted DNA sequencing for variant detection, innovate RNA sequencing by removing unwanted ribosomal RNA, and provide seamless data analysis solutions, all aimed at maximizing the true potential of NGS in biological research.Along with these vital insights from industry experts, the edition features Medizen Humancare a company that pioneers precision healthcare by leveraging personal genomic databases and predicting and preventing diseases before their onset. In this edition featuring the Top Genomics solutions Providers in APAC 2023, and Top Genomics Solutions Providers in South Korea 2023 we hope you find the appropriate company best suited to meet your business requirements. Let us know your thoughts!EDITORIALUnveiling the Genomic RevolutionCopyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com DECEMBER - 23 - 2023, Vol 04, Issue - 61 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersEdwin PaulDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >